EGFR and neoplasm: In this review, our aim is to provide an overview of the tumor-promoting effects exerted by the PI3K/AKT/mTOR signaling pathway in hepatocellular carcinoma (HCC), which is primarily triggered by the epidermal growth factor receptor (EGFR).